Disease · MONDO_0004247
Trials23
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs.
1 to 20 of 23
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02235311 | Optimal Dose of Proton Pump Inhibitors Following an Upper Gastrointestinal Bleed | Not applicable | 3 | 2017-07-02 | Upper Gastrointestinal Bleed | PANTOPRAZOLE | Its record names the disease | ClinicalTrials.gov |
| NCT01888588 | Risk of Uncomplicated Peptic Ulcer in the General Population | 4,000 | Peptic Ulcer [Iowa Type (107680.0010)] | ASPIRIN | Its record names the disease | ClinicalTrials.gov | ||
| NCT04810793 | The Study on the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure | 820 | Helicobacter Pylori | AMOXICILLIN, ESOMEPRAZOLE, FURAZOLIDONE, LEVOFLOXACIN, TETRACYCLINE, VONOPRAZAN FUMARATE | Its record names the disease | ClinicalTrials.gov | ||
| NCT00164866 | Administration of High-Dose Intravenous Proton Pump Inhibitor for Upper Gastrointestinal Bleeding Prior to Endoscopy | Phase 4 | 638 | Peptic Ulcer | OMEPRAZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT00374101 | High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding | Phase 3 | 450 | Peptic Ulcers, Upper Gastrointestinal Bleeding | OMEPRAZOLE, PANTOPRAZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT01760824 | Quadruple Versus Sequential Therapy for Helicobacter Pylori Eradication | Not applicable | 391 | Helicobacter Pylori Infection | AMOXICILLIN, BISMUTH SUBCITRATE, CLARITHROMYCIN, ESOMEPRAZOLE, METRONIDAZOLE, TETRACYCLINE | Its record names the disease | ClinicalTrials.gov | |
| NCT05035186 | Efficacy of Clarithromycin and Flouroquinolones Based Regimens in H.Pylori Eradication in Covid-19 Era | Not applicable | 233 | Helicobacter Pylori Infection | AMOXICILLIN, CLARITHROMYCIN, ESOMEPRAZOLE, LEVOFLOXACIN | Its record names the disease | ClinicalTrials.gov | |
| NCT01037491 | Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets | Not applicable | 200 | Gastric Ulcer, Duodenal Ulcer | ASPIRIN, CLOPIDOGREL, RABEPRAZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT04061447 | Tailored Juice-guided Eradication Therapy | Not applicable | 182 | Helicobacter Pylori Infection | CLARITHROMYCIN | Its record names the disease | ClinicalTrials.gov | |
| NCT00120315 | Proton Pump Inhibitor Treatment Stop | Phase 4 | 171 | Dyspepsia | ESOMEPRAZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT06894992 | Tegoprazan And Lansoprazole Effectiveness in Bleeding Peptic Ulcer Treatment | Not applicable | 162 | Peptic Ulcer Bleeding | LANSOPRAZOLE, TEGOPRAZAN | Its record names the disease | ClinicalTrials.gov | |
| NCT00519519 | Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic Ulcers | Phase 3 | 126 | Bleeding Peptic Ulcers Disease | OMEPRAZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT00261300 | Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708) | Phase 3 | 100 | Gastroesophageal Reflux Disease (GERD), Peptic Ulcers | PANTOPRAZOLE | Open Targets' reading of its record | ClinicalTrials.gov | |
| NCT04170270 | Oral Omeprazole in Bleeding Peptic Ulcer | Early phase 1 | 100 | Bleeding Peptic Ulcer | OMEPRAZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT05410223 | Efficacy and Safety Study of Egg Yolk Antibody in Adjuvant Treatment of Helicobacter Pylori Infection | Not applicable | 100 | Helicobacter Pylori Infection | AMOXICILLIN, CLARITHROMYCIN, DOXYCYCLINE, FURAZOLIDONE | Its record names the disease | ClinicalTrials.gov | |
| NCT07260006 | Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease | Not applicable | 80 | Helicobacter Pylori Infection, Peptic Ulcer | AMOXICILLIN, METRONIDAZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT04550858 | h.Pylori Ttt With Rebamipide | 60 | H.Pylori Infection | REBAMIPIDE | Its record names the disease | ClinicalTrials.gov | ||
| NCT01214408 | Effect of Digene Total (Buffered Pantoprazole) on 24 Hour Gastric Potential Hydrogen (pH) in Patients From Acid Peptic Disorder After Single and Repeated Dosing. | Phase 4 | 47 | Acid Peptic Disorder | PANTOPRAZOLE | Open Targets' reading of its record | ClinicalTrials.gov | |
| NCT05670457 | Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic Ulcer | Phase 3 | 44 | Non-bleeding Peptic Ulcer | DIOSMIN | Its record names the disease | ClinicalTrials.gov | |
| NCT02536989 | Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot | Phase 4 | 40 | Peptic Ulcer, Hemorrhage | OMEPRAZOLE | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0004247/trials